alpha1life.com
  • What is Alpha1
    Alpha1 Antitrypsin Deficiency
    What is Alpha1 AntitrypsinWhat is Alpha1 Antitrypsin DeficiencyPrevention Versus Cure4 Doctors and 7 YearsSymptoms152 DiseasesYour AgeHelping Alphas
    Non Deficient Patients
    BenefitsNew Alpha1 Antitrypsin UsesFirst RespondersHelping Non Alphas
    Standard of Care
    For Alpha1's
  • Newly Diagnosed
    Alpha1 Antitrypsin
    What is Alpha1 Antitrypsin Deficiency
    Previous Conditions
    FibromyalgiaLiver Disease with AATDLung Disease with AATDPanniculitis
    Alpha1 Life Findings
    Our Story152 Autoimmune DiseaseCancer
    Living with AATD
    What Now?Alpha1 SpecialistTreatmentAlpha1 & ChildrenSupport GroupsAlpha1 Community Videos
    Alpha1 Resources
    Family TestingPeriodicalsResearch RegistryInsurance InformationEducation
  • Get Involved
    Donate
    Donate NowMonthly Giving ProgramWays to GiveIn TributeEmployee GivingPlanned Giving
    Advocate
    Contact Your PolicymakersOur Public Policy PrioritiesAdvocacy ResourcesPolicy Updates

Prevention Versus Cure

The premise in Mark’s patent filing, “METHOD OF PREVENTING AND/OR TREATING A PLURALITY OF DISEASES,” is that with proper identification of Alpha1 Antitrypsin circulating levels, our research shows that, with proper circulating levels of Alpha1 Antitrypsin, we can prevent disease!

The body can be constantly bombarded with neutrophils trying to enter cells that could lead to malignant cancer growth and the conversion of the cyst into cancerous material. Regularly, the neutrophils can have the opportunity to enter the cells and eventually become malignant and therefore, constantly being bombarded with the potential of metastasizing cancer cells throughout the entire body. Let us help the medical community find the validity of what we can prevent in the future, starting now!